Novavax cleared to boost Australians over 18 years Federal Novavax is now recommended for Australians 18 years and over wanting a booster where an mRNA shot is not suitable.
Hotel quarantine winds down as $200m hub due to open, Novavax rolls out February 14, 2022 By Jackson Graham Health Operations at a new, 250-bed, quarantine hub located in Mickleham will start later this month.
Plans for Novavax to be rolled out, ACT to give RATs to students returning to classrooms January 25, 2022 By Jackson Graham Federal Federal health minister Greg Hunt says Australia had purchased 51 million doses of the Novavax vaccine.
New protein-based vax being fast tracked in Europe November 23, 2021 By Tom Ravlic News Novavax is having conditional marketing authorisation reviewed by European authorities for its protein-based coronavirus vaccine ‘Nuvaxovid’.
Novavax trialling its flu-COVID combo jab September 10, 2021 By Tom Ravlic Biotech company Novavax is kicking off its phase one clinical trial of a vaccine that combines the seasonal flu inoculation and a vaccination for the coronavirus.
Supply issues with COVID-19 shot sit on federal government’s shoulders, expert says June 17, 2021 By Melissa Coade Federal The government putting most of its ‘eggs in the AstraZeneca basket’ is behind Australia’s vaccine availability tightness, says biostats chair.
University of Queensland COVID-19 vaccine trial axed December 11, 2020 By Shannon Jenkins Federal The University of Queensland and biotech company CSL have pulled the plug on further trials of their COVID-19 vaccine after antibodies in the vaccine were found to interfere with HIV tests.
